Immunisering i svangerskapet

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 19, 2009, Pages 2016-2018

  Heier, Hans Erik ^a,b   Berge, Lillian Nordbø ^a   Hervig, Tor ^c,d   Kiserud, Torvid ^c,d   Børset, Magne ^e,f   Eik Nes, Sturla ^e,f   Arsenovic, Mirjana ^g   Acharya, Ganesh ^h,i  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g Avdeling for immunogi og transfusjonsmedisin   (Norway)

^h Kvinneklinikken   (Norway)

ⁱ UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

1A ALLOANTIGEN, HUMAN; IMMUNOLOGIC FACTOR; RHESUS D ANTIBODY; THROMBOCYTE ANTIGEN;

ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; NEUTROPENIA; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREGNANCY; RHESUS ISOIMMUNIZATION;

ANTIGENS, HUMAN PLATELET; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; NEUTROPENIA; PREGNANCY; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 70350488907     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.0186     Document Type: Article

References (11)

1. Mari G, Deter RL, Carpenter RL et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000; 342: 9-14.
2. Kornstad L. Fifteen years' experience with postpartum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women. NIPH Ann 1987; 10, nr. 1: 3-10.
3. Royal College of Obstetricians and Gynaecologists. www.rcog.org.uk/womens-health/clinicalguidance/use-anti-d-immunoglobulin-rhprophylaxis-green-top-22 (9.6.2009).
4. Hughes RG, Craig JI, Murphy WG et al. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990. Br J Obstet Gynaecol 1994; 101: 297-300.
5. Crowther C. Anti-D administration after childbirth for preventing rhesus alloimmunisation (Cochrane review). I: The Cochrane Library. Chichester, UK: John Wiley, 2003.
6. Norges Røde Kors Blodprogram. Blodtransfusjonstjenesten i Norge: Statistikk 2001-7. Oslo: Norges Røde Kors, 2002-8.
7. Kjeldsen-Kragh J, Killie MK, Tomter G et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110: 833-9.
8. Killie MK, Kjeldsen-Kragh J, Husebekk A et al. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia. BJOG 2007, 114: 588-95.
9. Fretheim A. Kritikk av norsk screeningstudie. Tidsskr Nor Legeforen 2008; 128: 2617.
10. Killie MK, Husebekk A, Kjeldsen-Kragh J et al. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008; 93: 870-7.
11. Tiller H. Kritisk søkelys på norsk screeningstudie. Tidsskr Nor Legeforen 2008; 128: 1982-4.